Annual report pursuant to Section 13 and 15(d)

Accrued Expenses And Other Current Liabilities

v3.19.1
Accrued Expenses And Other Current Liabilities
 12 Months Ended
Dec. 31, 2018
Accrued Liabilities and Other Liabilities [Abstract]  
Accrued Expenses and Other Current Liabilities
Accrued Expenses and Other Current Liabilities
 
Accrued expenses and other current liabilities as of December 31, 2018 and 2017 consisted of the following:
 
 
 
December 31,
 
 
2018
 
2017
Sales returns
 
$
3,972,510

 
$
3,478,349

Medicaid rebates
 
2,237,269

 
350,681

Minimum sales commitments, royalties payable, and purchase obligations
 
9,662,901

 
743,010

Compensation and benefits
 
1,953,065

 
1,401,514

Research and development expenses
 
278,132

 
299,480

General and administrative
 
1,112,378

 
1,001,454

Sales and marketing
 
235,721

 
—

Other
 
279,397

 
256,634

Total accrued expenses and other current liabilities
 
$
19,731,373

 
$
7,531,122